Ishares Trust Etf Profile
| IBRN Etf | USD 24.91 0.06 0.24% |
PerformanceVery Weak
| Odds Of DistressLow
|
IShares Trust is selling at 24.91 as of the 26th of February 2025; that is 0.24 percent decrease since the beginning of the trading day. The etf's open price was 24.97. IShares Trust has less than a 9 % chance of experiencing financial distress in the next few years, but has generated negative returns over the last 90 days. The performance scores are derived for the period starting the 27th of January 2025 and ending today, the 26th of February 2025. Click here to learn more.
The fund will invest at least 80 percent of its assets in the component securities of its index and in investments that have economic characteristics that are substantially identical to the component securities of its index and may invest up to 20 percent of its assets in certain futures, options and swap contracts, cash and cash equivalents as well as in securities not included in the index, but which BFA believes will help the fund track the index. More on iShares Trust
Moving together with IShares Etf
IShares Etf Highlights
| Thematic Ideas | (View all Themes) |
| Business Concentration | Strategy ETFs, Theme ETFs, Health, iShares (View all Sectors) |
| Issuer | iShares |
| Inception Date | 2022-08-24 |
| Benchmark | NYSE FactSet Global Neuro Biopharma and MedTech Index |
| Entity Type | Regulated Investment Company |
| Asset Under Management | 3.86 Million |
| Asset Type | Equity |
| Category | Strategy |
| Focus | Theme |
| Market Concentration | Blended Development |
| Region | Global |
| Administrator | State Street Bank and Trust Company |
| Advisor | BlackRock Fund Advisors |
| Custodian | State Street Bank and Trust Company |
| Distributor | BlackRock Investments, LLC |
| Portfolio Manager | Jennifer Hsui, Greg Savage, Paul Whitehead, Amy Whitelaw |
| Transfer Agent | State Street Bank and Trust Company |
| Fiscal Year End | 31-Jul |
| Exchange | NYSE Arca, Inc. |
| Number of Constituents | 62.0 |
| Market Maker | Flow Traders |
| Total Expense | 0.47 |
| Management Fee | 0.47 |
| 200 Day M A | 25.3738 |
| Country Name | USA |
| 50 Day M A | 25.8354 |
| Code | IBRN |
| Returns Y T D | (0.62) |
| Name | iShares Trust - iShares Neuroscience and Healthcare ETF |
| Currency Name | US Dollar |
| Currency Code | USD |
| Open Figi | BBG01920FLW8 |
| Type | ETF |
| 1y Volatility | 16.36 |
iShares Trust [IBRN] is traded in USA and was established 2022-08-24. The fund is listed under Health category and is part of iShares family. The entity is thematically classified as Strategy ETFs. iShares Trust currently have 4.95 M in assets under management (AUM). , while the total return for the last year was -0.3%.
Check IShares Trust Probability Of Bankruptcy
Geographic Allocation (%)
iShares Trust Currency Exposure
iShares Trust holds assets that are exposed to currency risk. As an investor, you have to ensure that the increase in value or dividend from foreign constituents of IShares Trust will not be offset by an unfavorable exchange rate and will not cancel out the return on assets from different countries. In other words, assess how much of your investment depends on the development of foreign currencies before you invest in iShares Trust .
Top iShares Trust Etf Constituents
| ACAD | ACADIA Pharmaceuticals | Stock | Health Care | |
| BHVN | Biohaven Pharmaceutical Holding | Stock | Health Care | |
| BIIB | Biogen Inc | Stock | Health Care | |
| NBIX | Neurocrine Biosciences | Stock | Health Care | |
| NVRO | Nevro Corp | Stock | Health Care | |
| SAVA | Cassava Sciences | Stock | Health Care | |
| SRPT | Sarepta Therapeutics | Stock | Health Care | |
| SUPN | Supernus Pharmaceuticals | Stock | Health Care |
iShares Trust Risk Profiles
The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in IShares Trust. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures.
| Risk Adjusted Performance | (0.06) | |||
| Jensen Alpha | (0.14) | |||
| Total Risk Alpha | (0.14) | |||
| Treynor Ratio | (0.21) |
IShares Trust Against Markets
Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in iShares Trust . Also, note that the market value of any etf could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area. To learn how to invest in IShares Etf, please use our How to Invest in IShares Trust guide.You can also try the Performance Analysis module to check effects of mean-variance optimization against your current asset allocation.
The market value of iShares Trust is measured differently than its book value, which is the value of IShares that is recorded on the company's balance sheet. Investors also form their own opinion of IShares Trust's value that differs from its market value or its book value, called intrinsic value, which is IShares Trust's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because IShares Trust's market value can be influenced by many factors that don't directly affect IShares Trust's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between IShares Trust's value and its price as these two are different measures arrived at by different means. Investors typically determine if IShares Trust is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, IShares Trust's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.